Ischemic stroke among the patients with end-stage renal disease who were undergoing maintenance dialysis

Yonsei Medical Journal

Volumn 53, Issue 5, 2012, Pages 894-900

  Jung, San ^a   Kwon, Seok Beom ^a   Hwang, Sung Hee ^a   Noh, Jung Woo ^a   Lee, Young Ki ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

Cholesterol; End stage renal disease; Hypertension; Ischemic stroke

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; UREA;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIAC EMBOLISM; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EMBOLISM; FEMALE; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; LABORATORY TEST; LARGE ARTERY ATHEROSCLEROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAINTENANCE THERAPY; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; SMALL VESSEL OCCLUSION; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UREA BLOOD LEVEL;

EID: 84864589356     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.5.894     Document Type: Article

References (33)

1. Jeong TK, Kim HS, Nah MY, Jeong GH, Jung K, Lee SC, et al. Serum lipids and lipoproteins in patients with chronic renal failure. Korean J Nephrol 1998;17:735-45.
2. Office KNS. Annual Report on the Cause of Death Statistics (Based on Vital Registration in Year 2005). Daejeon: Korea National Statistical Office; 2006 Contract No.: Document Number.
3. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke 1997;28:557-63.
4. Wang JG, Staessen JA, Fagard RH, Birkenhäger WH, Gong L, Liu L. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001;37:1069-74.
5. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993;44:1086-90.
6. Bos MJ, Koudstaal PJ, Hofman A, Breteler MM. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: the Rotterdam Study. Stroke 2007;38:3127-32.
7. Muntner P, Coresh J, Klag MJ, Whelton PK, Perneger TV. History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: an analysis of shared risk factors. Am J Kidney Dis 2002;40:323-30.
8. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002;13:1918-27.
9. Townsend RR. Stroke in chronic kidney disease: prevention and management. Clin J Am Soc Nephrol 2008;3 Suppl 1:S11-6.
10. Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 2003;14: 2623-31.
11. Weiner DE, Tighiouart H, Amin MG, Stark PC, McLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-15.
12. Mason NA, Bailie GR, Satayathum S, Bragg-Gresham JL, Akiba T, Akizawa T, et al. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005;45:119-26.
13. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005;353:238-48.
14. Khella SL. New insights into stroke in chronic kidney disease. Adv Chronic Kidney Dis 2008;15:338-46.
15. D'Elia JA, Weinrauch LA, Gleason RE, Lipinska I, Lipinski B, Lee AT, et al. Risk factors for thromboembolic events in renal failure. Int J Cardiol 2005;101:19-25.
16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
17. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988;19:547-54.
18. Iseki K, Fukiyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 1996;50:1672-5.
19. Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005;45:1058-66.
20. Segal AZ, Chiu RI, Eggleston-Sexton PM, Beiser A, Greenberg SM. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology 1999;18: 185-93.
21. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989;320:904-10.
22. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903-13.
23. Sozio SM, Armstrong PA, Coresh J, Jaar BG, Fink NE, Plantinga LC, et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis 2009;54:468-77.
24. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 2003;64:610-5.
25. Lee JH, Han SJ, Yun YH, Choi HC, Jung S, Cho SJ, et al. Posterior circulation ischemic stroke in Korean population. Eur J Neurol 2006;13:742-8.
26. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology 2007;68:556-62.
27. Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990;131:579-88.
28. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001;32:2575-9.
29. Sozio SM, Coresh J, Jaar BG, Fink NE, Plantinga LC, Armstrong PA, et al. Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis. Clin J Am Soc Nephrol 2011;6:1292-300.
30. Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246:2177-80.
31. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42:227-76.
32. Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998;279:1643-50.
33. Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 2011; 6:2662-8.